Table 2.
No. | Group | Immuno-suppression | Cortico-steroids | Others | Chemotherapygiven | pT | G | Pn | V | N | R | Lymph nodes at SL | Lymph Nodes at LT | Lymph Nodes positive |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | LT-Gem | tacrolimus | yes | MMF | yes | pT2 | G2 | Pn0 | V0 | N0 | R0 | 5 | 12 | 0 |
2 | LT alone | tacrolimus | yes | MMF | no | pT2 | G1 | Pn1 | V0 | N0 | R0 | 3 | 11 | 0 |
3 | LT alone | tacrolimus | yes | MMF | no | pT2 | G3 | Pn0 | V0 | N0 | R0 | 5 | 9 | 0 |
4 | LT alone | cyclosporin A | yes | MMF | no | pT2 | G2 | Pn1 | V0 | N1 | R0 | 1 | 8 | 1 |
5 | LT-Gem | tacrolimus | yes | MMF | yes | pT2 | G2 | Pn1 | V0 | N0 | R0 | 3 | 8 | 0 |
6 | LT-Gem | tacrolimus | yes | none | yes | pT2 | G2 | Pn1 | V0 | N1 | R0 | 3 | 6 | 3 |
No., Patient number; LT-Gem, liver transplantation and adjuvant gemcitabine (intervention group); LT alone, liver transplantation alone (control group); MMF, mycophenolate mofetil; SL, staging laparotomy; LT, liver transplantation.